Drug Channels
Pages
(Move to ...)
ABOUT
INDUSTRY REPORTS
WEBINARS
KEYNOTE SPEAKING
ADVERTISE
SUBSCRIBE / CONTACT
▼
Wednesday, July 29, 2020
Drug Channels News Roundup, July 2020: Diabetes Costs, Regeneron’s Copay Support, MA Rethinks Coupons, My Favorite Chart Updated, and ABC’s Steve Collis
›
The steamy, socially distanced days of summer are here. Cool off by getting up close and personal with our refreshing selection of articles ...
Sunday, July 26, 2020
Trump’s Executive Orders on Drug Pricing: The Drug Channels Guide to Industry Implications
›
Surprise! President Trump signed four executive orders (EO) last Friday afternoon. They cover: Pass-through of 340B discounts for insulin a...
Friday, July 24, 2020
Clarity in the Face of COVID-19: Building an Effective Patient Savings Strategy
›
Today’s guest post comes from Frank Dana, Chief Commercial Officer at ConnectiveRx. Frank discusses how the loss of commercial insurance c...
Thursday, July 23, 2020
How Hospitals and PBMs Profit—and Patients Lose—From 340B Contract Pharmacies
›
The stunning growth of specialty pharmacies in the 340B Drug Pricing Program has accelerated a troubling trend: Patients covered by commerc...
Tuesday, July 21, 2020
PBM-Owned Specialty Pharmacies Expand Their Role In—and Profits From—the 340B Program
›
Last week, I documented that nearly half of U.S. pharmacies now participate in the 340B Drug Pricing Program . Below, we update our exclus...
Tuesday, July 14, 2020
Walgreens and CVS Top the 28,000 Pharmacies Profiting from the 340B Program. Will the Unregulated Party End?
›
It’s time for our annual look at the 340B Drug Pricing Program’s booming pharmacy component. Our exclusive analysis of government data f...
Friday, July 10, 2020
CMS Best Price Proposal and Copay Assistance: How New Rule Could Change the Access Landscape
›
Today’s guest post comes from Rick Fry, Senior Vice President of Commercial Solutions and Jason Zemcik, Senior Director of Product Managemen...
Thursday, July 09, 2020
The Top 15 Specialty Pharmacies of 2019: PBMs Stay On Top (rerun)
›
This week (Monday through Thursday), I’m rerunning some popular posts. Click here to see the original post and comments from April 2020. ...
Wednesday, July 08, 2020
Four Unexpected Ways that the COVID-19 Medicaid Boom Will Affect PBM and Pharmacy Profits (rerun)
›
This week (Monday through Thursday), I’m rerunning some popular posts. Click here to see the original post and comments from April 2020. ...
Tuesday, July 07, 2020
Pharmacy DIR Fees Hit a Record $9 Billion in 2019—That’s 18% of Total Medicare Part D Rebates (rerun)
›
This week (Monday through Thursday), I’m rerunning some popular posts. Click here to see the original post and comments from February 2020...
Monday, July 06, 2020
The Top 15 U.S. Pharmacies of 2019: Specialty Drugs Drive the Industry’s Evolution (rerun)
›
This week (Monday through Thursday), I’m rerunning some popular posts. Click here to see the original post and comments from March 2020. N...
Wednesday, June 24, 2020
Drug Channels News Roundup, June 2020: CVS’s New GPO, CMS on Copay Accumulators, GoodRx Fees, Supermarket Pharmacies, and Merck’s Ken Frazier
›
Happy 244th birthday, America! Before you declare your (socially-distanced) independence, get up close and personal with these Drug Channe...
‹
›
Home
View web version